The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 15, 2015

Filed:

Sep. 18, 2008
Applicants:

Frances Balkwill, London, GB;

Violet Slettenaar, London, GB;

Julia Wilson, London, GB;

Yaohe Wang, London, GB;

Tiziana Schioppa, London, GB;

Inventors:

Frances Balkwill, London, GB;

Violet Slettenaar, London, GB;

Julia Wilson, London, GB;

Yaohe Wang, London, GB;

Tiziana Schioppa, London, GB;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); G01N 33/574 (2006.01); G01N 33/576 (2006.01); G01N 33/50 (2006.01); A61K 31/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5005 (2013.01); A61K 31/00 (2013.01); G01N 33/574 (2013.01); G01N 2800/52 (2013.01); G01N 2800/56 (2013.01);
Abstract

Chemokine receptor CCR4 and its ligands CCL1 7 and CCL22 are used as markers for the identification and/or staging of cancer. The level of CCR4, CCL17 and CCL22 are found to increase during malignant tumor progression. CCR4, CCL17 and CCL22 are used as markers for the stratification of cancer patients according to their suitability for treatment with anti-cancer agents. Information of diagnostic character is provided by measuring the level of one or more of CCR4, CCL 17 and CCL22 present in a patient sample. Methods of treatment of cancer patients which agents that modulate the activity of CCR4, CCL17 and CCL22. Methods of screening for agents which modulate the biological activities of CCR4, CCL 17 and CCL22 provide anti-cancer agents.


Find Patent Forward Citations

Loading…